TipRanks
Go Ultimate55% OFF

Sionna Therapeutics, Inc. (SION) Income Statement

Sionna Therapeutics, Inc. Income Statement

Last quarter (Q2 2026), Sionna Therapeutics, Inc.'s total revenue was $0.00. In Q2, Sionna Therapeutics, Inc.'s net income was $-29.89M. See Sionna Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22
$ 0.00$ 0.00$ 0.00$ 0.00
$ -647.00K$ -668.00K$ 0.00$ 0.00
$ 88.33M$ 69.89M$ 50.33M$ 41.37M
Depreciation and Amortization$ 647.00K$ 668.00K$ 583.00K$ 122.00K
$ -74.62M$ -61.02M$ -46.68M$ -40.12M
$ -88.98M$ -70.56M$ -50.33M$ -41.37M
$ 13.71M$ 8.87M$ 3.07M$ 1.13M
$ -75.27M$ -61.69M$ -47.26M$ -40.24M
$ -75.27M$ -61.69M$ -47.26M$ -40.24M
Per Share Metrics
Basic EPS$ -1.88$ -1.40$ -1.07$ -0.91
Diluted EPS$ -1.88$ -1.40$ -1.07$ -0.91
Weighted Average Shares Outstanding39.96M44.12M44.12M44.12M
Weighted Average Shares Outstanding (Diluted)39.96M44.12M44.12M44.12M

Currency in USD

Sionna Therapeutics, Inc. Earnings and Revenue History

-90M-60M-30M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin